{"id":352433,"date":"2010-02-23T04:40:05","date_gmt":"2010-02-23T09:40:05","guid":{"rendered":"http:\/\/www.treatgene.com\/?p=515"},"modified":"2010-02-23T04:40:05","modified_gmt":"2010-02-23T09:40:05","slug":"3-types-of-pro-apoptotic-proteins","status":"publish","type":"post","link":"https:\/\/mereja.media\/index\/352433","title":{"rendered":"3 Types of Pro-apoptotic Proteins"},"content":{"rendered":"<p><strong>Pro-apoptotic proteins<\/strong> are the proteins that induce and activate the <a title=\"apoptotic pathway\" href=\"http:\/\/www.treatgene.com\/apoptotic-pathway\/\">apoptotic pathway<\/a>. The antagonist of <strong>pro-apoptotic proteins<\/strong> are the anti-apoptotic proteins which inhibit and stop the apoptotic pathway. The pro-apoptotic and anti-apoptotic proteins can work together to maintain a dynamic balance between the survival and death of the cell. Today, we will discuss three types of <strong>pro-apoptotic proteins<\/strong>.<br \/>\n&nbsp;<\/p>\n<h2>Pro-apoptotic Protein &#8211; Bax<\/h2>\n<p>The pro-apoptotic Bax protein is another major player in <a title=\"apoptosis\" href=\"http:\/\/www.treatgene.com\/apoptosis-type-1-programmed-cell-death-pathway\/\">apoptosis<\/a> (Mojgan <em>et. al.<\/em>, 2002). Studies have proved that when Bax is activated, it creates discontinuity or pores in the outer mitochondrial membrane to regulate the release of cytochrome <em>c<\/em>. The intrinsic apoptotic pathway will not be activated in the absence of Bax-activating signals. In addition, cells lack of Bax protein will not undergo apoptosis even though there are death stimuli (Lei <em>et. al.<\/em>, 2006).<br \/>\n&nbsp;<br \/>\n<a href=\"http:\/\/www.treatgene.com\/wp-content\/uploads\/2010\/02\/pro-apoptotic-protein.jpg\"><img loading=\"lazy\" decoding=\"async\" class=\"alignright size-full wp-image-516\" title=\"pro-apoptotic protein\" src=\"http:\/\/www.treatgene.com\/wp-content\/uploads\/2010\/02\/pro-apoptotic-protein.jpg\" alt=\"pro-apoptotic protein\" width=\"214\" height=\"633\" \/><\/a><\/p>\n<h2>Pro-apoptotic Protein &#8211; Caspases<\/h2>\n<p>Caspases are a family of cysteine proteases that play a crucial role in apoptosis. When the caspases are exposed to a pro-apoptotic signal, the zymogen forms of caspases will proteolytically cleave and activated. The initiator caspases like caspase 8, caspase 9, and caspase 10 can split other caspases. The executioner caspases such as caspase 3, caspase 6 and caspase 7 cleave the death substrates. All caspases consists of a single cysteine at the enzyme catalytic site (Byung <em>et. al<\/em>., 2002). Both intrinsic and extrinsic pathways trigger pro-apoptotic caspases or pro-caspases via a process called caspase cascade (Avi <em>et. al.<\/em>, 2008).<br \/>\n&nbsp;<\/p>\n<h2>Pro-apoptotic Protein &#8211; p53<\/h2>\n<p>The p53 protein is a transcription factor and <strong>pro-apoptotic protein<\/strong>. It proliferates the transcriptional expression of several genes that involved when react to genotoxic agents like ionizing radiation and chemical therapeutic drugs. The p53 protein initiates the cell cycle arrest and DNA damage repair. If the cells cannot be repaired, the p53 protein will activates cell death programs and the cells then go through the apoptosis. Hence, p53 protein is a tumor suppressor protein against cancer development. The effective ways to prevent tumor growth and discard cancers are inhibit the cell proliferation and promote the apoptosis in tumors. Conventionally, chemotherapeutic agents that used to induce apoptosis are mediated mostly via p53-dependent pathways. Yet, most of human tumors have p53 mutations and inactivation (Luo <em>et. al.<\/em>, 2008). The p53 protein activates the expression of pro-apoptotic proteins, such as Bax and down regulates the expression of the anti-apoptotic protein like Bcl-2 (Byung <em>et. al<\/em>., 2002).<br \/>\n&nbsp;<br \/>\nIn conclusion, many therapeutic strategies can be designed to treat the <a title=\"cancer\" href=\"http:\/\/www.treatgene.com\/cancer-diseases\/\">cancer<\/a> by regulating the pro-apoptotic and anti-apoptotic proteins. <a title=\"cytogenetics cancer research\" href=\"http:\/\/www.treatgene.com\">Cancer research<\/a> on apoptotic pathway will really help us to design the most effective <a title=\"cancer treatment\" href=\"http:\/\/www.treatgene.com\/category\/cancer-treatment\/\">cancer treatment<\/a>.<\/p>\n<p><script type=\"text\/javascript\" class=\"owbutton\" src=\"http:\/\/www.onlywire.com\/btn\/button_5044\" title=\"3 Types of Pro-apoptotic Proteins\" url=\"http:\/\/www.treatgene.com\/types-of-pro-apoptotic-proteins\/\"><\/script><\/p>\n<p><a href=\"http:\/\/www.treatgene.com\/types-of-pro-apoptotic-proteins\/\">3 Types of Pro-apoptotic Proteins<\/a> is a post from: <a href=\"http:\/\/www.treatgene.com\">Cytogenetics and Cancer Research<\/a><\/p>\n<h2  class=\"related_post_title\">Related Posts<\/h2>\n<ul class=\"related_post\">\n<li><a href=\"http:\/\/www.treatgene.com\/top-10-discoveries-of-cancer-treatment-in-2009\/\" title=\"Top 10 Discoveries of Cancer Treatment in 2009\"><img decoding=\"async\" src=\"http:\/\/www.treatgene.com\/types-of-pro-apoptotic-proteins\/3769\" alt=\"Top 10 Discoveries of Cancer Treatment in 2009\" \/><\/a>December 6, 2009 &#8212; <a href=\"http:\/\/www.treatgene.com\/top-10-discoveries-of-cancer-treatment-in-2009\/\" title=\"Top 10 Discoveries of Cancer Treatment in 2009\">Top 10 Discoveries of Cancer Treatment in 2009<\/a> (12)<\/li>\n<li><a href=\"http:\/\/www.treatgene.com\/apoptosis-type-1-programmed-cell-death-pathway\/\" title=\"Apoptosis | Type 1 Programmed Cell Death Pathway\"><img decoding=\"async\" src=\"http:\/\/www.treatgene.com\/types-of-pro-apoptotic-proteins\/892\" alt=\"Apoptosis | Type 1 Programmed Cell Death Pathway\" \/><\/a>November 19, 2009 &#8212; <a href=\"http:\/\/www.treatgene.com\/apoptosis-type-1-programmed-cell-death-pathway\/\" title=\"Apoptosis | Type 1 Programmed Cell Death Pathway\">Apoptosis | Type 1 Programmed Cell Death Pathway<\/a> (0)<\/li>\n<li><a href=\"http:\/\/www.treatgene.com\/anti-angiogenic-therapy-to-treat-cancer\/\" title=\"Anti-angiogenic Therapy to Treat Cancer\"><img decoding=\"async\" src=\"http:\/\/www.treatgene.com\/types-of-pro-apoptotic-proteins\/70\" alt=\"Anti-angiogenic Therapy to Treat Cancer\" \/><\/a>March 4, 2010 &#8212; <a href=\"http:\/\/www.treatgene.com\/anti-angiogenic-therapy-to-treat-cancer\/\" title=\"Anti-angiogenic Therapy to Treat Cancer\">Anti-angiogenic Therapy to Treat Cancer<\/a> (0)<\/li>\n<li><a href=\"http:\/\/www.treatgene.com\/basic-ways-relieve-cancer-pain\/\" title=\"3 Basic Ways to Relieve Cancer Pain\"><img decoding=\"async\" src=\"http:\/\/www.treatgene.com\/types-of-pro-apoptotic-proteins\/264\" alt=\"3 Basic Ways to Relieve Cancer Pain\" \/><\/a>March 1, 2010 &#8212; <a href=\"http:\/\/www.treatgene.com\/basic-ways-relieve-cancer-pain\/\" title=\"3 Basic Ways to Relieve Cancer Pain\">3 Basic Ways to Relieve Cancer Pain<\/a> (7)<\/li>\n<\/ul>\n","protected":false},"excerpt":{"rendered":"<p>Pro-apoptotic proteins are the proteins that induce and activate the apoptotic pathway. The antagonist of pro-apoptotic proteins are the anti-apoptotic proteins which inhibit and stop the apoptotic pathway. The pro-apoptotic and anti-apoptotic proteins can work together to maintain a dynamic balance between the survival and death of the cell. Today, we will discuss three types [&hellip;]<\/p>\n","protected":false},"author":2194,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[7],"tags":[],"class_list":["post-352433","post","type-post","status-publish","format-standard","hentry","category-news"],"_links":{"self":[{"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/posts\/352433","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/users\/2194"}],"replies":[{"embeddable":true,"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/comments?post=352433"}],"version-history":[{"count":0,"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/posts\/352433\/revisions"}],"wp:attachment":[{"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/media?parent=352433"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/categories?post=352433"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/tags?post=352433"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}